{"id":67571,"date":"2025-05-09T00:02:40","date_gmt":"2025-05-09T00:02:40","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/05\/09\/beautyhealth-reports-first-quarter-2025-financial-results\/"},"modified":"2025-05-09T00:02:40","modified_gmt":"2025-05-09T00:02:40","slug":"beautyhealth-reports-first-quarter-2025-financial-results","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/beautyhealth-reports-first-quarter-2025-financial-results\/","title":{"rendered":"BeautyHealth Reports First Quarter 2025 Financial Results"},"content":{"rendered":"
\n

LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ: SKIN) (\u201cBeautyHealth\u201d or the “Company”), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March\u00a031, 2025 (\u201cQ1 2025\u201d).<\/p>\n

\u201cOur first quarter results reflect strong execution and continued momentum in our transformation strategy,\u201d said CEO Marla Beck. \u201cWe exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer demand.\u201d<\/p>\n

\u201cWe have taken decisive actions to expand profit margins and drive shareholder value\u2014relocating production to the U.S. to mitigate tariff risk and initiating the transition of our China operations to a distributor model. With a pipeline of impactful product launches and bold brand initiatives ahead, we believe we are well-positioned to deepen provider engagement, elevate consumer loyalty, and return the Company to sustainable long-term growth.\u201d<\/p>\n

Key Operational and Business Metrics<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\nThree Months Ended March 31,<\/strong><\/td>\n<\/tr>\n
Unaudited ($ in millions)<\/strong> (1)<\/strong><\/sup><\/td>\n\u00a0<\/td>\n2025<\/strong><\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n2024<\/strong><\/td>\n\u00a0<\/td>\n<\/tr>\n
Delivery Systems net sales<\/td>\n$<\/td>\n20.2<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n35.8<\/td>\n\u00a0<\/td>\n<\/tr>\n
Consumables net sales<\/td>\n\u00a0<\/td>\n49.4<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n45.6<\/td>\n\u00a0<\/td>\n<\/tr>\n
Total net sales<\/td>\n$<\/td>\n69.6<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n81.4<\/td>\n\u00a0<\/td>\n<\/tr>\n
Gross profit<\/td>\n$<\/td>\n48.6<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n48.4<\/td>\n\u00a0<\/td>\n<\/tr>\n
Gross margin<\/td>\n\u00a0<\/td>\n69.8<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n59.4<\/td>\n%<\/td>\n<\/tr>\n
Adjusted gross profit(2)<\/sup><\/td>\n$<\/td>\n50.0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n51.6<\/td>\n\u00a0<\/td>\n<\/tr>\n
Adjusted gross margin(2)<\/sup><\/td>\n\u00a0<\/td>\n71.9<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n63.4<\/td>\n%<\/td>\n<\/tr>\n
Net loss<\/td>\n$<\/td>\n(10.1<\/td>\n)<\/td>\n\u00a0<\/td>\n$<\/td>\n(0.7<\/td>\n)<\/td>\n<\/tr>\n
Adjusted EBITDA(2)<\/sup><\/td>\n$<\/td>\n7.3<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n$<\/td>\n0.4<\/td>\n\u00a0<\/td>\n<\/tr>\n
Adjusted EBITDA margin(2)<\/sup><\/td>\n\u00a0<\/td>\n10.4<\/td>\n%<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n0.4<\/td>\n%<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

<\/p>\n\n\n\n\n\n
\u00a0<\/td>\nThree Months Ended March 31,<\/strong><\/td>\n<\/tr>\n
Unaudited<\/strong><\/td>\n2025<\/strong><\/td>\n\u00a0<\/td>\n2024<\/strong><\/td>\n<\/tr>\n
Total delivery systems sold<\/td>\n862<\/td>\n\u00a0<\/td>\n1,417<\/td>\n<\/tr>\n
Active install base(3)<\/sup><\/td>\n35,014<\/td>\n\u00a0<\/td>\n32,530<\/td>\n<\/tr>\n<\/table>\n

__________________________
(1) Amounts may not sum due to rounding.
(2) See “Non-GAAP Financial Measures” below.
(3) Estimated number of delivery systems owned by providers that have purchased consumables in the trailing twelve-month period.<\/p>\n

BeautyHealth completed the first quarter of 2025 with an estimated active install base of 35,014 units, as compared to 32,530 in the prior year, resulting in growth in consumable net sales. The decrease in overall revenue resulted from fewer units placed year over year, impacted by a challenging macroeconomic environment. The Company continues to evaluate its strategic footprint and is transitioning its China market from a direct sales to distributor model in the second quarter of 2025.<\/p>\n

First<\/strong> Quarter Financial Highlights<\/strong><\/p>\n